单位：[1]ceuter for the assessment of pharmaceutical practies and pharmaceutical asscssment,management and policy program,department of health policy and management,boston university school of public health,boston,ma,usa[2]center for health quality outcomes and eco[3]center for health quality outcomes and econemic research,veteran affairs medical center,bedford,ma[4]department of surgery,massachusetts general hospital,boston,ma[5]division of research,epidemiology,etiology and prevention,kaiser pennanente,oakland,ca,usa[6]aging research center,karolimka institute,stockholm,sweden[7]maveric,va cooperative studies program,boston,ma[8]department of pharmacalogy and department of neurology,boston university school of medicine,boston,ma 02118-2526,usa[9]华中科技大学同济医院肿瘤科华中科技大学同济医学院附属同济医院肿瘤科
第一作者单位：[1]ceuter for the assessment of pharmaceutical practies and pharmaceutical asscssment,management and policy program,department of health policy and management,boston university school of public health,boston,ma,usa[2]center for health quality outcomes and eco
推荐引用方式(GB/T 7714)：
Nien-Chen Li,Austin Lee,Rachel A Whitmer,等.血管紧张素受体阻断剂预防男性人群痴呆发生风险研究:前瞻性队列分析[J].英国医学杂志（中文版）.2010,13(2):108-109.
